Standout Papers

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or afliberc... 2014 2026 2018 2022 274
  1. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD (2014)
    Robert L. Avery, Alessandro Castellarin et al. British Journal of Ophthalmology

Immediate Impact

1 from Science/Nature 76 standout
Sub-graph 1 of 22

Citing Papers

Age-Related Macular Degeneration
2024 Standout
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
2 intermediate papers

Works of Robert F. See being referenced

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
2017
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
2014 Standout

Author Peers

Author Last Decade Papers Cites
Robert F. See 1018 546 160 162 27 1.2k
A C McCartney 772 312 74 170 45 1.1k
Bora Eldem 1291 846 121 174 53 1.5k
M. Hope–Ross 865 681 43 184 30 1.5k
Froncie A. Gutman 1004 544 92 126 39 1.2k
Marilyn C. Kincaid 771 216 71 222 55 1.2k
Allen B. Thach 1287 682 64 362 29 1.6k
Charles C. Barr 1245 710 46 183 56 1.6k
Genevieve Larkin 602 273 128 104 19 1.2k
F. D. Kitchin 697 157 55 204 30 1.1k
Judith Kingston 699 230 43 278 34 1.2k

All Works

Loading papers...

Rankless by CCL
2026